S-4 S-4 EX-FILING FEES 0001625297 Indivior Pharmaceuticals, Inc. N/A N/A 0001625297 2026-08-27 2026-08-27 0001625297 1 2026-08-27 2026-08-27 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-4

Indivior Pharmaceuticals, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value $0.001 per share Other 103,231,296 $ 3,018,984,178.24 0.0001381 $ 416,921.72
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 3,018,984,178.24

$ 416,921.72

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 416,921.72

Offering Note

1

Rule 457(f) Fee Calculation Details

Represents the estimated maximum number of shares of common stock, par value $0.001 per share ("Indivior Shares") of the registrant ("Indivior") estimated to be issued to holders of shares of common stock, par value $0.001 per share ("Supernus Shares") of Supernus Pharmaceuticals, Inc. ("Supernus") in connection with the consummation of the merger of Artemis Merger Sub Inc., a wholly owned subsidiary of Indivior, with and into Supernus, with Supernus surviving as a wholly owned subsidiary of Indivior (the "Merger"), as described in the accompanying joint proxy statement/prospectus. The number of Indivior Shares being registered is based upon the product of (A) 1.5401, the exchange ratio for the Merger and (B) the sum of (i) 58,220,949, the number of shares of Supernus common stock outstanding as of August 25, 2026, (ii) 1,587,249, the number of Supernus common stock issuable in respect of restricted stock units granted, or are expected to be granted prior to the closing of the Merger, under a Supernus equity plan that is subject to solely time-based vesting restrictions and not performance-based metrics ("Supernus RSUs"), (iii) 465,383, the number of Supernus common stock issuable in respect of Supernus RSUs that are subject to performance-based vesting restrictions, (iv) 6,655,375, the number of Supernus common stock issuable in respect of each option to acquire Supernus common stock granted under a Supernus equity plan or pursuant to a stand-alone stock option agreement and (v) 100,000, the number of Supernus common stock and/or Supernus common stock issuable underlying Supernus equity awards reserved for grants prior to the closing of the Merger. Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended (the "Securities Act"), and calculated pursuant to Rules 457(f)(1) and 457(c) of the Securities Act. The proposed maximum aggregate offering price of the Indivior Shares was calculated on the basis of (i) $45.04, the average of the high and low prices per share of Supernus common stock, on NASDAQ Global Market on August 25, 2026 multiplied by (ii) 67,028,956, the maximum number of shares of Supernus common stock (including in respect of Supernus equity awards) estimated to be converted or exchanged in the Merger. Calculated pursuant to Section 6(b) of the Securities Act at a rate equal to $138.10 per $1,000,000 of the proposed maximum aggregate offering price.
Amount of Securities to be Received or Cancelled Value per Share of Securities to be Received or Cancelled Total Value of Securities to be Received or Cancelled Cash Consideration Received by the registrant Cash Consideration (Paid) by the registrant Maximum Aggregate Offering Price
67,028,956 $ 45.04 $ 3,018,984,178.24 $ 3,018,984,178.24

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date